We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRO icon
2151
Spero Therapeutics
SPRO
$72.4M
$184K ﹤0.01%
9,977
AKBA icon
2152
Akebia Therapeutics
AKBA
$246M
$184K ﹤0.01%
63,726
+31,245
+96% +$89.2K
VPG icon
2153
Vishay Precision Group
VPG
$937M
$183K ﹤0.01%
5,267
XPRO icon
2154
Expro Ltd
XPRO
$2.07B
$183K ﹤0.01%
10,352
HCCI
2155
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$183K ﹤0.01%
6,299
XMTR icon
2156
Xometry
XMTR
$5.42B
$182K ﹤0.01%
+3,160
New +$219K
JOUT icon
2157
Johnson Outdoors
JOUT
$512M
$182K ﹤0.01%
1,720
GCMG icon
2158
GCM Grosvenor
GCMG
$2.81B
$181K ﹤0.01%
15,754
ADV icon
2159
Advantage Solutions
ADV
$411M
$181K ﹤0.01%
838
-392
-32% -$91.9K
AD
2160
Array Digital Infrastructure
AD
$3.08B
$180K ﹤0.01%
5,651
FNKO icon
2161
Funko
FNKO
$338M
$180K ﹤0.01%
9,888
BGFV
2162
DELISTED
Big 5 Sporting Goods
BGFV
$180K ﹤0.01%
7,812
CRBU icon
2163
Caribou Biosciences
CRBU
$164M
$180K ﹤0.01%
+7,531
New +$184K
RVI
2164
DELISTED
Retail Value Inc. Common Shares
RVI
$180K ﹤0.01%
74,278
FCBC icon
2165
First Community Bankshares
FCBC
$936M
$179K ﹤0.01%
5,650
-2,820
-33% -$85.2K
APPH
2166
DELISTED
AppHarvest, Inc. Common Stock
APPH
$179K ﹤0.01%
27,468
+7,923
+41% +$78.7K
ENDP
2167
DELISTED
Endo International plc
ENDP
$179K ﹤0.01%
55,094
-30,190
-35% -$107K
ERAS icon
2168
Erasca
ERAS
$6.36B
$177K ﹤0.01%
+8,360
New +$172K
RGP icon
2169
Resources Connection
RGP
$145M
$177K ﹤0.01%
11,231
+6,924
+161% +$104K
TSHA icon
2170
Taysha Gene Therapies
TSHA
$1.96B
$177K ﹤0.01%
9,509
RLMD icon
2171
Relmada Therapeutics
RLMD
$514M
$177K ﹤0.01%
6,754
PCT icon
2172
PureCycle Technologies
PCT
$1.43B
$177K ﹤0.01%
13,329
AMTX icon
2173
Aemetis
AMTX
$126M
$176K ﹤0.01%
+9,652
New +$107K
HONE
2174
DELISTED
HarborOne Bancorp
HONE
$176K ﹤0.01%
12,519
-6,268
-33% -$86.8K
ALHC icon
2175
Alignment Healthcare
ALHC
$2.82B
$176K ﹤0.01%
10,996

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.